Cronos Group Inc. CRON

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $3.13
Market Cap $1.18B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑19.5% YoY
$193.36M
3-Yr CAGR: 19.1%
Net Income ↓-123.0% YoY
-$9.45M
Net Margin: -4.9%
Free Cash Flow ↓-97.7% YoY
$149.00K
FCF Yield: 0.01%
EPS (Diluted) ↓-118.2% YoY
$-0.02
Basic: $-0.02
Return on Equity Efficiency
-0.9%
ROA: -113.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CRON)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $0.9M $0.2M $-1.2M $-6.5M $-8.0M
FY 2017 $9.0M +868.6% $2.0M $2.5M +309.3% $-5.5M $-48.2M -503.2%
FY 2018 $15.7M +74.9% $8.0M $-19.2M -871.0% $-9.7M $-124.1M -157.3%
FY 2019 $25.6M +63.3% $-17.9M $1,166.5M +6,174.0% $3.33 $-130.0M $-168.7M -35.9%
FY 2020 $54.4M +112.0% $-25.8M $-73.1M -106.3% $-0.21 -106.3% $-142.5M $-173.9M -3.1%
FY 2021 $89.5M +64.6% $-17.5M $-396.1M -441.6% $-1.07 -409.5% $-153.6M $-164.8M +5.2%
FY 2022 $114.5M +27.9% $12.0M $-168.7M +57.4% $-88.9M $-92.4M +43.9%
FY 2023 $120.3M +5.1% $11.9M $-74.0M +56.2% $-0.19 $-42.8M $-45.3M +50.9%
FY 2024 $161.8M +34.5% $25.2M $41.1M +155.5% $0.11 +157.9% $18.8M $6.4M +114.2%
FY 2025 $193.4M +19.5% $62.8M $-9.4M -123.0% $-0.02 -118.2% $25.9M $0.1M -97.7%
$

Valuation

Market Price $3.13
Market Cap $1.18B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 1.07
FCF Yield 0.01%
Dividend Yield N/A
Shares Outstanding 373,662,000
%

Profitability & Margins

Gross Margin 32.46%
Operating Margin -9.00%
Net Margin -4.89%
Return on Equity (ROE) -0.86%
Return on Assets (ROA) -113.22%
Asset Turnover 23.17x
Revenue 3-Yr CAGR 19.10%
🛡️

Financial Health & Liquidity

Current Ratio 0.23
Cash Ratio 21.87
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $791.79M
Total Debt N/A
Book Value / Share $2.93
💧

Cash Flow Efficiency

Operating Cash Flow $25.87M
Capital Expenditures (CapEx) $25.72M
Free Cash Flow $149.00K
OCF / Revenue 13.38%
FCF / Revenue 0.08%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.02
EPS (Basic) $-0.02
Dividends / Share N/A
Book Value / Share $2.93
EPS YoY Growth -118.18%
🏛️

Balance Sheet (FY 2025)

Total Assets $8.34M
Total Liabilities $36.21M
Stockholders' Equity $1.09B
Current Assets $8.34M
Current Liabilities $36.21M